OICR News / Tag

Open source

Browse news tagged Open source.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Talent

Analyzing SARS-CoV-2: A cancer researcher trainee’s perspective

OICR-based PhD Candidate awarded University of Toronto COVID-19 Student Engagement Award This scanning electron microscope image shows SARS-CoV-2 (round blue objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as…

ArticleSep 03, 2020

Technology

New open-source software judges accuracy of algorithms that predict tumour evolution

Adriana Salcedo OICR-led international research group develops new open-source software to determine the accuracy of computational methods that can map the genetic history of tumour cells. A cancer patient’s tumour is often made up of…

ArticleJan 10, 2020

Technology

Open source in open science: Accelerating cancer research (Part 2)

Find part 1 here: Open source in open science: Accelerating cancer research OICR researchers have contributed to major open source projects available to the global research community in order to accelerate cancer research. Click the…

ArticleAug 03, 2018

Technology

Open source in open science: Accelerating cancer research (Part 1)

In the effort to bring better disease prevention and treatment to patients faster, cancer researchers are thinking more creatively about ways to conduct high-quality scientific research. Concerns about the quality, efficiency and reproducibility of research…

ArticleAug 01, 2018

Talent

OICR’s Cancer Genome Collaboratory wins 2018 OpenStack Superuser award for contributions to the cancer research community

Based on popular vote and review by the Superuser Editorial Advisory Board, OICR’s Cancer Genome Collaboratory team has won the 2018 OpenStack Vancouver Summit Superuser Award. The Award recognizes OICR’s use of OpenStack, an open-source…

ArticleMay 23, 2018

TechnologyBreast cancer

Novel approach yields four robust biomarkers for breast cancer drug response

Biomarkers that can help predict a patient’s response to a given drug are central to testing new therapies in clinical trials as well as selecting which drugs to use in the clinic. Some of the…

ArticleNov 02, 2017

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Open source

Discover the latest news and insightsDiscover the latest news and insights

Tagged stories

Analyzing SARS-CoV-2: A cancer researcher trainee’s perspective

New open-source software judges accuracy of algorithms that predict tumour evolution

Open source in open science: Accelerating cancer research (Part 2)

Cancer solved together — in your inbox

Open source in open science: Accelerating cancer research (Part 1)

OICR’s Cancer Genome Collaboratory wins 2018 OpenStack Superuser award for contributions to the cancer research community

Novel approach yields four robust biomarkers for breast cancer drug response